Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events - ILLUMINATE - Presented at AHA 2007


The goal of the trial was to evaluate the effect of treatment with torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, in addition to atorvastatin compared with atorvastatin alone on clinical events among patients at high risk for cardiovascular events.